(2R)-2-[2-(2,1,3-benzoxadiazol-5-ylmethoxy)-4-[[2-bromo-3-[3-[5-(hydroxymethyl)-1,3,4-oxadiazol-2-yl]-2-methylphenyl]phenyl]methoxy]-5-chloroanilino]-3-hydroxypropanoic acid

C33H27BrClN5O8 — CID 169101341

IUPAC(2R)-2-[2-(2,1,3-benzoxadiazol-5-ylmethoxy)-4-[[2-bromo-3-[3-[5-(hydroxymethyl)-1,3,4-oxadiazol-2-yl]-2-methylphenyl]phenyl]methoxy]-5-chloroanilino]-3-hydroxypropanoic acid
SMILESCc1c(-c2nnc(CO)o2)cccc1-c1cccc(COc2cc(OCc3ccc4nonc4c3)c(N[C@H](CO)C(=O)O)cc2Cl)c1Br
InChIInChI=1S/C33H27BrClN5O8/c1-17-20(5-3-6-21(17)32-38-37-30(14-42)47-32)22-7-2-4-19(31(22)34)16-46-28-12-29(26(11-23(28)35)36-27(13-41)33(43)44)45-15-18-8-9-24-25(10-18)40-48-39-24/h2-12,27,36,41-42H,13-16H2,1H3,(H,43,44)/t27-/m1/s1
InChIKeyOILGZKKTNABJOX-HHHXNRCGSA-N
MW736.96 g/mol
LogP6.17
Rot. Bonds13

About (2R)-2-[2-(2,1,3-benzoxadiazol-5-ylmethoxy)-4-[[2-bromo-3-[3-[5-(hydroxymethyl)-1,3,4-oxadiazol-2-yl]-2-methylphenyl]phenyl]methoxy]-5-chloroanilino]-3-hydroxypropanoic acid

(2R)-2-[2-(2,1,3-benzoxadiazol-5-ylmethoxy)-4-[[2-bromo-3-[3-[5-(hydroxymethyl)-1,3,4-oxadiazol-2-yl]-2-methylphenyl]phenyl]methoxy]-5-chloroanilino]-3-hydroxypropanoic acid (PubChem CID 169101341) has the molecular formula C33H27BrClN5O8 and a molecular weight of 736.96 g/mol. Its IUPAC name is (2R)-2-[2-(2,1,3-benzoxadiazol-5-ylmethoxy)-4-[[2-bromo-3-[3-[5-(hydroxymethyl)-1,3,4-oxadiazol-2-yl]-2-methylphenyl]phenyl]methoxy]-5-chloroanilino]-3-hydroxypropanoic acid.

Molecular Properties

Compound Name(2R)-2-[2-(2,1,3-benzoxadiazol-5-ylmethoxy)-4-[[2-bromo-3-[3-[5-(hydroxymethyl)-1,3,4-oxadiazol-2-yl]-2-methylphenyl]phenyl]methoxy]-5-chloroanilino]-3-hydroxypropanoic acid
PubChem CID169101341
Molecular FormulaC33H27BrClN5O8
Molecular Weight736.96 g/mol
Exact Mass735.07
IUPAC Name(2R)-2-[2-(2,1,3-benzoxadiazol-5-ylmethoxy)-4-[[2-bromo-3-[3-[5-(hydroxymethyl)-1,3,4-oxadiazol-2-yl]-2-methylphenyl]phenyl]methoxy]-5-chloroanilino]-3-hydroxypropanoic acid
SMILESCc1c(-c2nnc(CO)o2)cccc1-c1cccc(COc2cc(OCc3ccc4nonc4c3)c(N[C@H](CO)C(=O)O)cc2Cl)c1Br
InChIInChI=1S/C33H27BrClN5O8/c1-17-20(5-3-6-21(17)32-38-37-30(14-42)47-32)22-7-2-4-19(31(22)34)16-46-28-12-29(26(11-23(28)35)36-27(13-41)33(43)44)45-15-18-8-9-24-25(10-18)40-48-39-24/h2-12,27,36,41-42H,13-16H2,1H3,(H,43,44)/t27-/m1/s1
InChIKeyOILGZKKTNABJOX-HHHXNRCGSA-N
XLogP6.17
TPSA186.09 Ų
H-Bond Donors4
H-Bond Acceptors12
Rotatable Bonds13
Heavy Atoms48
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500736.96
LogP ≤ 56.17
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1012

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'anil_di_alk_C(246)', 'substructure': 'N/A'}

Analyze (2R)-2-[2-(2,1,3-benzoxadiazol-5-ylmethoxy)-4-[[2-bromo-3-[3-[5-(hydroxymethyl)-1,3,4-oxadiazol-2-yl]-2-methylphenyl]phenyl]methoxy]-5-chloroanilino]-3-hydroxypropanoic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (2R)-2-[2-(2,1,3-benzoxadiazol-5-ylmethoxy)-4-[[2-bromo-3-[3-[5-(hydroxymethyl)-1,3,4-oxadiazol-2-yl]-2-methylphenyl]phenyl]methoxy]-5-chloroanilino]-3-hydroxypropanoic acid?
The IUPAC name of (2R)-2-[2-(2,1,3-benzoxadiazol-5-ylmethoxy)-4-[[2-bromo-3-[3-[5-(hydroxymethyl)-1,3,4-oxadiazol-2-yl]-2-methylphenyl]phenyl]methoxy]-5-chloroanilino]-3-hydroxypropanoic acid (CID 169101341) is (2R)-2-[2-(2,1,3-benzoxadiazol-5-ylmethoxy)-4-[[2-bromo-3-[3-[5-(hydroxymethyl)-1,3,4-oxadiazol-2-yl]-2-methylphenyl]phenyl]methoxy]-5-chloroanilino]-3-hydroxypropanoic acid.
What is the SMILES notation for (2R)-2-[2-(2,1,3-benzoxadiazol-5-ylmethoxy)-4-[[2-bromo-3-[3-[5-(hydroxymethyl)-1,3,4-oxadiazol-2-yl]-2-methylphenyl]phenyl]methoxy]-5-chloroanilino]-3-hydroxypropanoic acid?
The canonical SMILES for (2R)-2-[2-(2,1,3-benzoxadiazol-5-ylmethoxy)-4-[[2-bromo-3-[3-[5-(hydroxymethyl)-1,3,4-oxadiazol-2-yl]-2-methylphenyl]phenyl]methoxy]-5-chloroanilino]-3-hydroxypropanoic acid is Cc1c(-c2nnc(CO)o2)cccc1-c1cccc(COc2cc(OCc3ccc4nonc4c3)c(N[C@H](CO)C(=O)O)cc2Cl)c1Br.
What is the InChIKey of (2R)-2-[2-(2,1,3-benzoxadiazol-5-ylmethoxy)-4-[[2-bromo-3-[3-[5-(hydroxymethyl)-1,3,4-oxadiazol-2-yl]-2-methylphenyl]phenyl]methoxy]-5-chloroanilino]-3-hydroxypropanoic acid?
The InChIKey is OILGZKKTNABJOX-HHHXNRCGSA-N. The full InChI is InChI=1S/C33H27BrClN5O8/c1-17-20(5-3-6-21(17)32-38-37-30(14-42)47-32)22-7-2-4-19(31(22)34)16-46-28-12-29(26(11-23(28)35)36-27(13-41)33(43)44)45-15-18-8-9-24-25(10-18)40-48-39-24/h2-12,27,36,41-42H,13-16H2,1H3,(H,43,44)/t27-/m1/s1.
What are the key properties of (2R)-2-[2-(2,1,3-benzoxadiazol-5-ylmethoxy)-4-[[2-bromo-3-[3-[5-(hydroxymethyl)-1,3,4-oxadiazol-2-yl]-2-methylphenyl]phenyl]methoxy]-5-chloroanilino]-3-hydroxypropanoic acid?
(2R)-2-[2-(2,1,3-benzoxadiazol-5-ylmethoxy)-4-[[2-bromo-3-[3-[5-(hydroxymethyl)-1,3,4-oxadiazol-2-yl]-2-methylphenyl]phenyl]methoxy]-5-chloroanilino]-3-hydroxypropanoic acid has a molecular weight of 736.96 g/mol, XLogP of 6.17, 13 rotatable bonds, 4 hydrogen bond donors, and 12 hydrogen bond acceptors.
Where does this data come from?
All data for (2R)-2-[2-(2,1,3-benzoxadiazol-5-ylmethoxy)-4-[[2-bromo-3-[3-[5-(hydroxymethyl)-1,3,4-oxadiazol-2-yl]-2-methylphenyl]phenyl]methoxy]-5-chloroanilino]-3-hydroxypropanoic acid is sourced from PubChem (CID 169101341), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).